From these perspectives, signalling modulation of the NCOA4‐mediator ferritinophagy–ferroptosis axis may generate a hopeful strategy for drug‐resistant cancer cells on account of different sensitivity to ferritinophagy and response to ferroptosis. Here, NCOA4 is linked to cancer.